06 October 2025 | News
Image Courtesy: Public Domain
Koh Young Technology, a neurosurgical robotics innovator, announced it will present its FDA-cleared navigated neurosurgical positioning robot, Geniant® Cranial at the upcoming Congress of Neurological Surgeons (CNS) "Special Symposium: Transforming Neurosurgery through Technology," taking place on October 12, 2025.
The special symposium showcases cutting-edge neurosurgical technology innovations across the complete development spectrum, featuring four distinct sections: pre-submission medical devices in early development, medical devices currently under FDA evaluation, FDA-cleared medical devices focused on clinical adoption and market integration, and established medical devices with continued innovation.
Koh Young will present in the FDA-cleared medical devices section, highlighting how Geniant Cranial—ready for immediate hospital adoption—can help advance surgical outcomes and operational efficiency in stereotactic neurosurgical procedures. Speaker Dr. Michael Levy, chief of pediatric neurosurgery at Rady's Children-San Diego, will present a comparative evaluation of operating room efficiency between Geniant Cranial and an established neurosurgical navigation platform.
Geniant Cranial received FDA clearance in January 2025. The stereotactic robotic guidance system is an upgraded version of its predecessor KYMERO, which received South Korean regulatory approval in 2016 and has been used in over 600 neurosurgical procedures—including epilepsy, Parkinson's disease, brain tumors, and other complex neurological conditions. KYMERO was launched and marketed exclusively in South Korea.
Geniant Cranial builds on KYMERO's proven core technology for clinical accuracy and safety, with added capabilities including enhanced user experience, improved ease of operation, expanded patient positioning flexibility, and greater accuracy compared to its predecessor, according to a Koh Young representative.
The CNS Annual Meeting is one of the largest and most influential global gatherings in neurosurgery, bringing together thousands of neurosurgeons, researchers, hospital leaders, and industry innovators each year. Known for its focus on advancing clinical practice and highlighting the latest technologies, this year's CNS, held in Los Angeles from October 11-15, looks to draw over 3,000 attendees from across the globe.
